Abstract
The basic anatomical and oncological properties of oropharyngeal cancer with appropriate radiological images are presented. The description is mainly divided into two categories; primary lesion and metastatic lymph nodes. Each of the categories is discussed in terms of the anatomy, oncology and current radiological imaging with emerging methods, such as FDG PET/CT and MRI diffusion imaging. Some interesting cases of lymphatic metastasis are also presented. A brief description on post-treatment observation of the disease is also given.
Keywords: Anatomy of oropharynx, HPV-related nodes, MRI diffusion imaging, oropharyngeal cancer, PET/CT, radiological images.
Graphical Abstract
Current Cancer Therapy Reviews
Title:Radiology of Oropharyngeal Cancer - Institutional Experience and Literature Review -
Volume: 11 Issue: 1
Author(s): Ko Matsumoto
Affiliation:
Keywords: Anatomy of oropharynx, HPV-related nodes, MRI diffusion imaging, oropharyngeal cancer, PET/CT, radiological images.
Abstract: The basic anatomical and oncological properties of oropharyngeal cancer with appropriate radiological images are presented. The description is mainly divided into two categories; primary lesion and metastatic lymph nodes. Each of the categories is discussed in terms of the anatomy, oncology and current radiological imaging with emerging methods, such as FDG PET/CT and MRI diffusion imaging. Some interesting cases of lymphatic metastasis are also presented. A brief description on post-treatment observation of the disease is also given.
Export Options
About this article
Cite this article as:
Matsumoto Ko, Radiology of Oropharyngeal Cancer - Institutional Experience and Literature Review -, Current Cancer Therapy Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573394711666150428003306
DOI https://dx.doi.org/10.2174/1573394711666150428003306 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Current Medicinal Chemistry New Targets for the Modulation of Radiation Response - Selective Inhibition of the Enzyme Cyclooxygenase 2
Current Medicinal Chemistry - Anti-Cancer Agents Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials Evaluation of the Ability of an Organic Derivative of Ruthenium(II) to Reinforce the Cytotoxicity of Fast Neutron Against Malignant Cells in Culture
Letters in Drug Design & Discovery Application of Molecular Diagnostics to the Evaluation of the Surgical Approach to Thyroid Cancer
Current Genomics Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests
Anti-Cancer Agents in Medicinal Chemistry The Quinoline Imidoselenocarbamate EI201 Blocks the AKT/mTOR Pathway and Targets Cancer Stem Cells Leading to a Strong Antitumor Activity
Current Medicinal Chemistry Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Liposome Encapsulated All Trans Retinoic Acid (ATRA) has Enhanced Immunomodulatory and Inflammation Reducing Activities in Mice Model
Anti-Cancer Agents in Medicinal Chemistry Boronated DNA-Binding Compounds as Potential Agents for Boron Neutron Capture Therapy
Mini-Reviews in Medicinal Chemistry Repressing the Activity of Protein Kinase CK2 Releases Mitochondria-Mediated Apoptosis in Cancer Cells
Current Drug Targets Pathway Analysis for Design of Promiscuous Drugs and Selective Drug Mixtures
Current Drug Discovery Technologies Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies A Novel Sentinel Lymph Node Approach in Oral Squamous Cell Carcinoma
Current Pharmaceutical Design Biosynthetic and Metabolic Alterations in Cancer Growth
Current Angiogenesis (Discontinued) Prognostic and Predictive Molecular Markers in Cutaneous Malignant Melanoma: The First Step Toward Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry